Full Press Release Details
PETMED EXPRESS D/B/A 1-800-PETMEDS
ANNOUNCES THIRD QUARTER FINANCIAL RESULTS
Earnings Increase 18% to $0.25 EPS
Net Sales Increase 11% to $48.4 million
Reorder Sales Increase 17% to $37.6 Million
Pompano Beach, Florida, January 19, 2010 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2009. Net income was $5.6 million or $0.25 diluted per share for the quarter ended December 31, 2009, compared to net income of $4.9 million or $0.21 diluted per share for the quarter ended December 31, 2008, an 18% increase to EPS. For the nine months ended December 31, 2009, net income was $19.9 million or $0.88 diluted per share, compared to net income of $17.3 million or $0.73 diluted per share for the nine months ended December 31, 2008, an increase to earnings per share of 20%. Net sales for the quarter ended December 31, 2009 were $48.4 million, compared to $43.4 million for the quarter ended December 31, 2008, an increase of 11%. Net sales for the nine months ended December 31, 2009 were $188.0 million, compared to $171.3 million for the nine months ended December 31, 2008, an increase of 10%. Reorder sales increased by 17%, from $32.2 million to $37.6 million for the quarters ended December 31, 2008 and 2009, respectively. Reorder sales for the nine months ended December 31, 2009 were $137.4 million, compared to $119.6 million for the nine months ended December 31, 2008, an increase of 15%.
Menderes Akdag, President and CEO, commented: We are pleased to report that our internet sales increased by 18% to $33.6 million for the quarter, compared to $28.6 million for the same quarter the prior year, with approximately 70% of our orders being generated from our website during the quarter, compared to 66% in the prior year. During the quarter, the Company leveraged its operating expenses as a percent of sales, by 170 basis points as compared to the same quarter in the prior year. We acquired approximately 151,000 new customers in the December quarter. We are also pleased to report that our cash flows from operations increased to $28.9 million for the nine months ended December 31, 2009 from $15.8 million for the same period the prior year. Going forward, our continuing focus will be on capturing additional market share, increasing reorders with personalized communication and health education content, and improving our customer service levels in fiscal 2010.
This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (210) 234-0009. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 19, 2010 until February 2, 2010 at 11:59 P.M. To access the replay, call (866) 511-5160 (toll free) or (203) 369-1959, and enter passcode 5500.
Founded in 1996, PetMed Express is America s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
This press release may contain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such forward-looking statements are set forth in Management s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2009. The Company s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K. For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.
PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
| December 31, | March 31, | |||
| 2009 | 2009 | |||
| (UNAUDITED) | ||||
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | $ | 56,601,631 | $ | 30,126,041 |
| Accounts receivable, less allowance for doubtful | ||||
| accounts of $24,066 and $58,525, respectively | 1,181,931 | 2,881,085 | ||
| Inventories - finished goods | 19,025,264 | 26,778,096 | ||
| Prepaid expenses and other current assets | 784,653 | 753,602 | ||
| Deferred tax assets | 1,150,445 | 724,561 | ||
| Prepaid income taxes | 1,801,818 | 361,743 | ||
| Total current assets | 80,545,742 | 61,625,128 | ||
| Long term investments | 12,312,500 | 14,430,250 | ||
| Property and equipment, net | 4,644,969 | 5,057,561 | ||
| Intangible assets | 850,000 | 850,000 | ||
| Total assets | $ | 98,353,211 | $ | 81,962,939 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | $ | 3,477,508 | $ | 4,817,097 |
| Accrued expenses and other current liabilities | 2,010,330 | 2,177,838 | ||
| Total current liabilities | 5,487,838 | 6,994,935 | ||
| Deferred tax liabilities | 544,016 | - | ||
| Total liabilities | 6,031,854 | 6,994,935 | ||
| Commitments and contingencies | ||||
| Shareholders' equity: | ||||
| Preferred stock, $.001 par value, 5,000,000 shares authorized; | ||||
| 2,500 convertible shares issued and outstanding with a | ||||
| liquidation preference of $4 per share | 8,898 | 8,898 | ||
| Common stock, $.001 par value, 40,000,000 shares authorized; | ||||
| 22,846,686 and 22,686,836 shares issued and outstanding, respectively | 22,847 | 22,687 | ||
| Additional paid-in capital | 1,957,983 | - | ||
| Retained earnings | 90,519,129 | 75,156,169 | ||
| Accumulated other comprehensive loss | (187,500) | (219,750) | ||
| Total shareholders' equity | 92,321,357 | 74,968,004 | ||
| Total liabilities and shareholders' equity | $ | 98,353,211 | $ | 81,962,939 |
PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
| Three Months Ended | Nine Months Ended | |||||||
| December 31, | December 31, | |||||||
| 2009 | 2008 | 2009 | 2008 | |||||
| Sales | $ | 48,353,607 | $ | 43,405,846 | $ | 187,969,366 | $ | 171,341,670 |
| Cost of sales | 29,525,562 | 26,088,572 | 116,172,990 | 105,375,803 | ||||
| Gross profit | 18,828,045 | 17,317,274 | 71,796,376 | 65,965,867 | ||||
| Operating expenses: | ||||||||
| General and administrative | 4,929,385 | 5,019,183 | 17,199,443 | 16,448,431 | ||||
| Advertising | 5,176,965 | 4,899,893 | 22,800,595 | 23,619,602 | ||||
| Depreciation and amortization | 336,834 | 185,649 | 981,647 | 503,277 | ||||
| Total operating expenses | 10,443,184 | 10,104,725 | 40,981,685 | 40,571,310 | ||||
| Income from operations | 8,384,861 | 7,212,549 | 30,814,691 | 25,394,557 | ||||
| Other income: | ||||||||
| Interest income, net | 46,091 | 297,017 | 164,678 | 958,735 | ||||
| Other, net | 1,162 | (27,616) | 3,829 | 301,835 | ||||
| Total other income | 47,253 | 269,401 | 168,507 | 1,260,570 | ||||
| Income before provision for income taxes | 8,432,114 | 7,481,950 | 30,983,198 | 26,655,127 | ||||
| Provision for income taxes | 2,841,964 | 2,597,182 | 11,053,267 | 9,328,053 | ||||
| Net income | $ | 5,590,150 | $ | 4,884,768 | $ | 19,929,931 | $ | 17,327,074 |
| Net income per common share: | ||||||||
| Basic | $ | 0.25 | $ | 0.21 | $ | 0.88 | $ | 0.74 |
| Diluted | $ | 0.25 | $ | 0.21 | $ | 0.88 | $ | 0.73 |
| Weighted average number of common shares outstanding: | ||||||||
| Basic | 22,649,491 | 23,333,025 | 22,596,204 | 23,446,990 | ||||
| Diluted | 22,789,731 | 23,542,120 | 22,742,196 | 23,627,969 | ||||
| Cash dividends declared per common share | $ | 0.10 | $ | - | $ | 0.20 | $ | - |
PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||||
| December 31, | ||||
| 2009 | 2008 | |||
| Cash flows from operating activities: | ||||
| Net income | $ | 19,929,931 | $ | 17,327,074 |
| Adjustments to reconcile net income to net cash | ||||
| provided by operating activities: | ||||
| Depreciation and amortization | 981,647 | 503,277 | ||
| Share based compensation | 1,158,015 | 1,089,889 | ||
| Deferred income taxes | 118,132 | 313,094 | ||
| Bad debt expense | 28,928 | 48,656 | ||
| (Increase) decrease in operating assets | ||||
| and increase (decrease) in liabilities: | ||||
| Accounts receivable | 1,670,226 | (549,255) | ||
| Inventories - finished goods | 7,752,832 | (1,745,221) | ||
| Prepaid income taxes | (1,440,075) | (4,000,000) | ||
| Prepaid expenses and other current assets | (31,051) | 30,283 | ||
| Accounts payable | (1,055,672) | 119,499 | ||
| Income taxes payable | - | 2,500,771 | ||
| Accrued expenses and other current liabilities | (205,446) | 146,009 | ||
| Net cash provided by operating activities | 28,907,467 | 15,784,076 | ||
| Cash flows from investing activities: | ||||
| Net change in investments | 2,150,000 | (1,620,000) | ||
| Purchases of property and equipment | (852,972) | (1,747,889) | ||
| Purchase of intangible asset | - | (485,000) | ||
| Net cash provided by (used in) investing activities | 1,297,028 | (3,852,889) | ||
| Cash flows from financing activities: | ||||
| Dividends paid | (4,529,033) | - | ||
| Purchases of treasury stock | - | (6,776,696) | ||
| Proceeds from the exercise of stock options | 573,918 | 1,535,035 | ||
| Tax benefit related to stock options exercised | 226,210 | 233,188 | ||
| Net cash used in financing activities | (3,728,905) | (5,008,473) | ||
| Net increase in cash and cash equivalents | 26,475,590 | 6,922,714 | ||
| Cash and cash equivalents, at beginning of period | 30,126,041 | 20,267,829 | ||
| Cash and cash equivalents, at end of period | $ | 56,601,631 | $ | 27,190,543 |
| Supplemental disclosure of cash flow information: | ||||
| Cash paid for income taxes | $ | 12,149,000 | $ | 10,281,000 |
| Retirement of treasury stock | $ | - | $ | 6,810,973 |
| Property and equipment purchases in accounts payable | $ | 487,842 | $ | 1,801,026 |
| Dividends payable in accrued expenses | $ | 37,938 | $ | - |